Delivery Order SPE2DB20D3101-SPE2DB24FRNB1

Award Date 6/17/24
Potential Completion Date 6/18/24
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of ELIQUIS 5 MG TABLET 60S. The firm-fixed-price delivery order has a ceiling value of $6,137.17 and a period of performance through March 3, 2025. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a range of pharmaceutical products and medical supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of ELIQUIS 5 MG TABLET 60S. The contract has a ceiling value of $12,841.17 and is a firm fixed-price delivery order with an ultimate completion date of August 16, 2024. The contract is not set aside for any specific business type. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,022.67 firm fixed-price delivery order is for the provision of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The award has an ultimate completion date of January 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation is for the delivery of pharmaceutical products, specifically 4566659400 ELIQUIS 5 MG TABLET 60S. The contract has a ceiling value of $18,301.78 and runs through December 10, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, is the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $14,229.48, is a delivery order contract for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has a period of performance through July 25, 2024 and utilizes a firm fixed-price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,401.88 delivery order contract is for the supply of ELIQUIS 5 MG TABLET 60S, a medication used for various medical conditions. The contract has an ultimate completion date of January 22, 2025 and is a Firm Fixed Price type. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any...
This federal contract award, valued at $24,177.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of June 21, 2024 and is a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ELIQUIS 5 MG TABLET 60S. The contract is a Delivery Order with a Firm Fixed Price, valued at $25,289.01, and has an Ultimate Completion Date of November 22, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, issued by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order valued at $1,378.86 and awarded to AmerisourceBergen Drug Corp. The contract is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of November 26, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
This federal contract award, valued at $3,394.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has a period of performance through September 25, 2023 and is a firm fixed-price contract. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRNB1
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of ELIQUIS 5 MG TABLET 60S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $18,216.18 and a period of performance through June 18, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp also holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 10:16 AM